Yahoo Finance • 3 months ago

Sage Therapeutics, Inc. (SAGE): Worst 52-Week Low Stock to Buy Now

We recently compiled a list of the 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers.In this article, we are going to take a look at where Sage Therapeutics, Inc. (NASDAQ:SAGE) stands against the other Worst 52-Week Low Sto... Full story

Yahoo Finance • 3 months ago

Sage Therapeutics, Inc. (SAGE) Hits 52-Week Lows After Trial Failures, According to Short Sellers

We recently published a list of 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers. In this article, we are going to take a look at where Sage Therapeutics, Inc. (NASDAQ:SAGE) stands against the other worst 52-week low stock... Full story

Yahoo Finance • 8 months ago

12 Best Depressed Stocks To Buy in 2024

In this article, we will take a detailed look at the 12 Best Depressed Stocks To Buy in 2024. For a quick overview of the 5 such stocks, read our article5 Best Depressed Stocks To Buy in 2024. JPMorgan Chief Jamie Dimon, in his latest let... Full story

Yahoo Finance • last year

Biogen’s Earnings Top Estimates. Watch for Updates on Its Alzheimer’s Drug.

Wall Street is interested in updates on future developments, rather than the latest quarter's numbers. Continue reading... Full story

Yahoo Finance • last year

Sage Therapeutics Inc (SAGE) Announces Q3 2023 Financial Results and Highlights Pipeline Progress

Sage Therapeutics Inc (NASDAQ:SAGE) reported Q3 2023 financial results with a strong financial foundation of $876 million in cash, cash equivalents and marketable securities. The company announced the expected wholesale acquisition cost of... Full story

Yahoo Finance • last year

Bragar Eagel & Squire, P.C. Is Investigating DigitalOcean, and Sage and Encourages Investors to Contact the Firm

NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against DigitalOcean Holdings, Inc. (NYSE: DOCN), and Sage Therapeutics, Inc... Full story

Yahoo Finance • last year

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sage Therapeutics, Inc. - SAGE

NEW YORK, Sept. 01, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. (“Sage” or the “Company”) (NASDAQ: SAGE).   Such investors are advised to contact Robert S. Willoughby a... Full story

Yahoo Finance • last year

Sage Therapeutics, Inc.: Company Investigated by the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Sage Therapeutics, Inc. (NASDAQ: SAGE) investors that the firm has ini... Full story

Yahoo Finance • last year

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Sage Therapeutics (SAGE) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Sage Therapeutics, Inc. (NASDAQ: SAGE) investors who suffered substantial losses to submit your losses now. Visit:www.hbsslaw.com/investor-fraud/sage Contact An Attor... Full story

Yahoo Finance • last year

Bragar Eagel & Squire, P.C. Is Investigating Blink, Lovesac, and Sage and Encourages Investors to Contact the Firm

NEW YORK, Aug. 27, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Blink Charging Co. (NASDAQ: BLNK), Lovesac Company (NASDAQ: LOVE), an... Full story

Yahoo Finance • last year

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Reminds Sage Therapeutics (SAGE) Investors with Substantial Losses to Contact Firm’s Attorneys, Firm Investigating Possible Securities Law Violations

SAN FRANCISCO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Hagens Berman urges Sage Therapeutics, Inc. (NASDAQ: SAGE) investors who suffered substantial losses to submit your losses now. Visit:www.hbsslaw.com/investor-fraud/sage Contact An Attor... Full story

Yahoo Finance • last year

15 Most Important Medical Discoveries in History

In this article, we take a look at the 15 most important medical discoveries in history. You can skip our detailed analysis of the global medicine industry and go directly to the 5 Most Important Medical Discoveries in History. Medical di... Full story

Yahoo Finance • 2 years ago

Sage Therapeutics and Biogen Share Update on FDA Advisory Committee for Zuranolone

CAMBRIDGE, Mass., March 08, 2023--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced that the U.S. Food and Drug Administration (FDA) notified the companies that the agency does not currently p... Full story

Yahoo Finance • 2 years ago

Sage Therapeutics to Present at the Cowen 43rd Annual Health Care Conference

CAMBRIDGE, Mass., February 28, 2023--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the Cowe... Full story

Yahoo Finance • 2 years ago

Biogen and Sage Therapeutics Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression

Zuranolone is being evaluated as a potential 14-day, rapid-acting, once-daily, oral medication to treat major depressive disorder (MDD) and postpartum depression (PPD) Depression is a public health issue with significant unmet medical need... Full story

Yahoo Finance • 2 years ago

Sage Therapeutics Stock Scores Relative Strength Rating Upgrade

Sage Therapeutics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.... Full story

Yahoo Finance • 2 years ago

Investors in Sage Therapeutics (NASDAQ:SAGE) have unfortunately lost 79% over the last three years

It's not possible to invest over long periods without making some bad investments. But you have a problem if you face massive losses more than once in a while. So consider, for a moment, the misfortune of Sage Therapeutics, Inc. (NASDAQ:SA... Full story

Yahoo Finance • 2 years ago

Best bang for the buck: Which CEOs are a bargain for shareholders?

We analyzed the 100 largest public companies in Mass. by both stock price performance in 2021 and CEO compensation.... Full story

Yahoo Finance • 3 years ago

10 Market-Moving Stocks to Watch on Monday

In this article, we will discuss 10 market-moving stocks to watch today. To take a look at some more stocks that are trending, go to 5 Market-Moving Stocks to Watch on Monday. Following April's tumultuous trading, investors are preparing... Full story